R&D Views & Analysis | pharmaphorum

Views & Analysis

Patients

How a once-weekly insulin could disrupt diabetes management ...

Insulin has been used to manage diabetes for a century, and while many advances have been made for people with both type 1 and type 2 diabetes – many more continue to be made.

R&D

Reconfiguring COVID and influenza vaccines for long-term eff...

Alexandre Le Vert, CEO and co-founder of Osivax, discusses the company's breakthrough vaccine technology, oligoDOM, and how it's driving the development of new influenza and SARS-CoV-2 vacc

R&D

Keeping the pandemic at bay with needle-free vaccine deliver...

COVID-19 is still circulating and there are fears that further spikes in cases are to be expected in the coming months.

R&D

Almirall/Lilly lebrikizumab offers potential long-term manag...

Atopic dermatitis (AD) is a highly prevalent chronic dermatological disease, with symptoms which include itching, dry skin, severe pain, and inflammation – all of which create considerable

Patients

How these parents of a child with a rare disease are making ...

When parents and physicians Drs Zachary and Geri Landman learned that their newborn daughter Lucy had an ultra-rare genetic condition, they were devastated.

R&D